Clincial Outcome Study 2
With the end of the first COS study, we are now looking to the future and what more is needed to prepare us for clinical trials in dysferlinopathy. This led to the development of COS2, which will evaluate 200 patients at 4 visits over 2 years. Sign up to participate and be part of the process of developing potential treatments for dysferlinopathy.
An opportunity for patients with dysferlinopathies to participate in a clinical research study. This study is essential for finding outcomes that can be measured during clinical trials. Without good clinical outcomes, effective clinical trials cannot be performed.
Read more...